Cardiac Monitoring Market 2020 Global Share, Trend, Segmentation and Forecast to 2027

The global Cardiac Monitoring Market size was estimated at USD 19.71 billion in 2019, according to the study by Reports and Data, and is projected to hit USD 26.83 billion by 2027, with a 3.9% CAGR. Cardiac monitoring is an ongoing or sporadic supervision of the heart that is done by ECG. The increase in heart diseases, obesity, the increasing elderly population, detrimental lifestyle, alcohol intake, and developments in the healthcare sector are factors that boost the demand for cardiac monitoring.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3362

WHO has stated that the leading cause of death worldwide is the increase in heart-related diseases. An estimated 17.9 million people are killed each year by cardiac diseases. One of the best options for tracking multiple heart conditions is cardiac monitoring. Vascular health is affected by obesity and leads to a greater risk of cardiovascular disease. Obesity contributes to an increase in blood volume and cardiac production, and these improvements increase stress on the arterial wall, the thickness and width of the vessel wall, the proliferation of smooth muscle cells, and ultimately contribute to heart-related disorders. It is expected that the prevalence will rise, gradually leading to a rising occurrence of heart-related disorders, thereby boosting demand in the market for cardiac monitoring.

Another major factor driving the cardiac monitoring market is favorable reimbursement policies, in addition to a wider target population. With a revenue of USD 8.69 billion, North America led the market for cardiac monitoring in 2019. The area is expected to remain dominant over the coming years due to the higher incidence of obesity and associated heart diseases and the adoption of developed technologies. Another significant driving force that enhances market growth is the emergence of advanced products in the industry. In March 2020, for example, QT Medical, a U.S.-based company, introduced a home ECG test that provides skilled nursing facilities and telehealth service providers with a cost-effective alternative. However, the key constraints on this sector are the high expenditure on diagnosis, care and stringent regulatory product approval procedures.

Impact of COVID-19 on Cardia Monitoring Market:

It is expected that the pandemic outbreak of COVID-19 will stimulate the cardiac monitoring market. The virus attacks the body's respiratory system, leading to heart function being disrupted. Therefore, for any arrhythmia, monitoring the vital signs is critical. Patients with heart-related conditions are also susceptible to infection, which is of great concern. Several regulatory bodies have relaxed guidelines for the clearance of cardiac monitoring products in order to ensure the required supply-demand balance. For example, to monitor cardiac activities in COVID-19 patients, the FDA granted VitalConnect with Emergency Utilization Approval (EUA).

In addition, by introducing new medicines or expanding the use of existing drugs, such as antimalarial or anti-retroviral drugs, researchers are working to create desirable therapies. In addition, it is estimated that the production of remote monitoring products to further diagnose vital signs for critical patients as well as infected patients and prevent accidental infection by market players would further enhance growth.

To identify the key trends in the industry, click on the link below: 
https://www.reportsanddata.com/report-detail/cardiac-monitoring-market

Key players of the cardiac monitoring market include:

  • Medtronic (Ireland)
  • Boston Scientific (U.S.)
  • Abbott Laboratories (U.S.)
  • GE Healthcare (U.S)
  • BIOTRONIK (Germany)
  • Hill-Rom Holding (U.S.)
  • Koninklijke Philips (Netherlands)
  • Livanova (U.K.)
  • Schiller AG (Switzerland)
  • Biotelemetry (U.S.)
  • Applied Cardiac System (U.S.)

For the purpose of this report, Reports and Data has segmented the Cardiac Monitoring Market on the basis of type, end-use, and region:            

Type Outlook (Revenue in Million USD; 2017–2027)

  • ECG devices
    • Product
      • Resting ECG Devices
      • Stress ECG Devices
      • Holter Monitors
    • Lead
      • Single Lead ECG Wires
      • ECG Lead Wires
      • Others
    • Event Monitors
      • Product
        • Pre Symptom Loop
        • Post Symptom Loop
      • Technology
        • Auto Detect
        • Manual Detect
      • Cardiac Output Monitoring
        • Invasive Cardiac Output Monitoring
        • Non-Invasive Cardiac Output Monitoring
      • Implantable Loop Recorders
      • Mobile Cardiac Telemetry Monitoring(MCT)
      • Smart wearable ECG monitors
      • Cardiac Rhythm Monitors
        • Defibrillators
          • Implantable Cardioverter Defibrillators
          • External Defibrillators
        • Pacemaker

End-Use outlook (Revenue in Million USD; 2017–2027)              

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers,
  • Home Care Settings

Regional Outlook (Revenue in Million USD; 2017–2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
  • Middle East & Africa

Read More News about Cardiac Monitoring Market report by Reports And Data:

Cardiac Monitoring Market:- https://www.prnewswire.com/news-releases/cardiac-monitoring-market-to-reach-usd-26-83-billion-by-2027--cagr3-9--reports-and-data-301100201.html

Contact Us

John W

Head of Business Development

40 Wall St. 28th floor New York City

NY 10005 United States

Direct Line: +1-212-710-1370